These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 20605301)

  • 1. Serum bicarbonate and long-term outcomes in CKD.
    Menon V; Tighiouart H; Vaughn NS; Beck GJ; Kusek JW; Collins AJ; Greene T; Sarnak MJ
    Am J Kidney Dis; 2010 Nov; 56(5):907-14. PubMed ID: 20605301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index and mortality in CKD.
    Madero M; Sarnak MJ; Wang X; Sceppa CC; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
    Am J Kidney Dis; 2007 Sep; 50(3):404-11. PubMed ID: 17720519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
    Levey AS; Greene T; Sarnak MJ; Wang X; Beck GJ; Kusek JW; Collins AJ; Kopple JD
    Am J Kidney Dis; 2006 Dec; 48(6):879-88. PubMed ID: 17162142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
    Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
    Menon V; Kopple JD; Wang X; Beck GJ; Collins AJ; Kusek JW; Greene T; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2009 Feb; 53(2):208-17. PubMed ID: 18950911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid and long-term outcomes in CKD.
    Madero M; Sarnak MJ; Wang X; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
    Am J Kidney Dis; 2009 May; 53(5):796-803. PubMed ID: 19303683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study.
    Kovesdy CP; Trivedi BK; Anderson JE
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):183-8. PubMed ID: 16580621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke.
    Ani C; Ovbiagele B
    J Neurol Sci; 2010 Jan; 288(1-2):123-8. PubMed ID: 19853862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
    Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease.
    van Kuijk JP; Flu WJ; Chonchol M; Welten GM; Verhagen HJ; Bax JJ; Poldermans D
    Nephrol Dial Transplant; 2010 Jun; 25(6):1882-8. PubMed ID: 20061315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum T3 level can predict cardiovascular events and all-cause mortality rates in CKD patients with proteinuria.
    Yang JW; Han ST; Song SH; Kim MK; Kim JS; Choi SO; Han BG
    Ren Fail; 2012; 34(3):364-72. PubMed ID: 22260378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial.
    Cianciaruso B; Pota A; Bellizzi V; Di Giuseppe D; Di Micco L; Minutolo R; Pisani A; Sabbatini M; Ravani P
    Am J Kidney Dis; 2009 Dec; 54(6):1052-61. PubMed ID: 19800722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
    Lambert ND; Sacrinty MT; Ketch TR; Turner SJ; Santos RM; Daniel KR; Applegate RJ; Kutcher MA; Sane DC
    Am Heart J; 2009 Apr; 157(4):688-94. PubMed ID: 19332197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.